Total Payments
$2,192
2023 Payments
$104.17
Companies
18
Transactions
145
Medicare Patients
3,188
Medicare Billing
$347,793
Payment Breakdown by Category
Food & Beverage$2,175 (99.2%)
Education$17.01 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,175 | 142 | 99.2% |
| Education | $17.01 | 3 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $486.98 | 36 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $312.23 | 23 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $251.36 | 17 | $0 (2020) |
| Novo Nordisk Inc | $246.17 | 16 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $224.16 | 15 | $0 (2020) |
| SANOFI PASTEUR INC. | $127.14 | 6 | $0 (2020) |
| Centinel Spine, LLC | $104.17 | 1 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $90.58 | 7 | $0 (2021) |
| Allergan, Inc. | $79.92 | 6 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $54.26 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $104.17 | 1 | Centinel Spine, LLC ($104.17) |
| 2021 | $145.78 | 10 | Lilly USA, LLC ($93.67) |
| 2020 | $177.73 | 11 | AstraZeneca Pharmaceuticals LP ($31.80) |
| 2019 | $351.67 | 23 | Lilly USA, LLC ($80.11) |
| 2018 | $722.67 | 49 | Novo Nordisk Inc ($169.79) |
| 2017 | $690.37 | 51 | Janssen Pharmaceuticals, Inc ($200.22) |
All Payment Transactions
145 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/13/2023 | Centinel Spine, LLC | PRODISC L (Device) | Food and Beverage | Cash or cash equivalent | $104.17 | General |
| Category: Spine Implant | ||||||
| 06/28/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: NEUROSCIENCE | ||||||
| 06/09/2021 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLUJAN | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/02/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $11.39 | General |
| Category: Neuroscience | ||||||
| 04/21/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: NEUROSCIENCE | ||||||
| 04/14/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Diabetes | ||||||
| 03/22/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: NEUROSCIENCE | ||||||
| 02/24/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Diabetes | ||||||
| 02/17/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Neuroscience | ||||||
| 01/27/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE, TRIJARDY XR | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Diabetes | ||||||
| 01/20/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Neuroscience | ||||||
| 11/16/2020 | SANOFI PASTEUR INC. | FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological), FLUZONE QUADRIVALENT, MENQUADFI | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Vaccines | ||||||
| 11/02/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/02/2020 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/16/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Diabetes | ||||||
| 02/05/2020 | Boston Scientific Corporation | SUPERION (Device) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: PAIN MANAGEMENT | ||||||
| 01/27/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/24/2020 | AngioDynamics, Inc. | — | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: VIT | ||||||
| 01/22/2020 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: Diabetes | ||||||
| 01/13/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.44 | General |
| Category: Cardiovascular | ||||||
| 01/08/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/18/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/16/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Central Nervous System (CNS) | ||||||
| 10/07/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.28 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 303 | 350 | $88,488 | $28,723 |
| 2022 | 11 | 828 | 1,206 | $296,570 | $102,415 |
| 2021 | 14 | 879 | 1,287 | $212,571 | $106,255 |
| 2020 | 17 | 1,178 | 1,682 | $149,907 | $110,399 |
Total Patients
3,188
Total Services
4,525
Medicare Billing
$347,793
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 116 | 142 | $41,464 | $12,077 | 29.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 81 | 81 | $24,138 | $10,841 | 44.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 70 | 85 | $17,510 | $4,245 | 24.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 36 | 42 | $5,376 | $1,560 | 29.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 199 | 375 | $109,500 | $30,380 | 27.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 197 | 197 | $58,700 | $26,927 | 45.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 183 | 303 | $62,418 | $17,983 | 28.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 39 | 39 | $14,664 | $6,911 | 47.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 18 | 79 | $12,324 | $4,670 | 37.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 24 | 27 | $11,745 | $4,557 | 38.8% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 17 | 17 | $7,939 | $2,998 | 37.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 58 | 71 | $9,088 | $2,900 | 31.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 33 | 33 | $4,026 | $2,259 | 56.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 22 | 27 | $4,266 | $1,651 | 38.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 38 | 38 | $1,900 | $1,180 | 62.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 229 | 412 | $78,394 | $33,316 | 42.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 214 | 214 | $46,944 | $30,157 | 64.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 180 | 343 | $47,030 | $21,593 | 45.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 21 | 68 | $7,708 | $3,923 | 50.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 16 | 20 | $6,430 | $3,238 | 50.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 17 | 17 | $4,502 | $3,029 | 67.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 20 | 20 | $3,869 | $2,034 | 52.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 22 | 29 | $3,251 | $1,654 | 50.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 31 | 34 | $3,937 | $1,514 | 38.4% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 23 | 23 | $2,806 | $1,501 | 53.5% |
About Dr. Thomas Flach, DO
Dr. Thomas Flach, DO is a Family Medicine healthcare provider based in Western Springs, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306933320.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Flach, DO has received a total of $2,192 in payments from pharmaceutical and medical device companies, with $104.17 received in 2023. These payments were reported across 145 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($2,175).
As a Medicare-enrolled provider, Flach has provided services to 3,188 Medicare beneficiaries, totaling 4,525 services with total Medicare billing of $347,793. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Western Springs, IL
- Active Since 10/10/2006
- Last Updated 08/07/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1306933320
Products in Payments
- XARELTO (Drug) $312.23
- ELIQUIS (Drug) $224.16
- TRULICITY (Drug) $187.90
- TRADJENTA (Drug) $148.04
- FARXIGA (Drug) $123.44
- Victoza (Drug) $121.73
- PRODISC L (Device) $104.17
- HUMALOG (Drug) $85.07
- Ozempic (Drug) $80.02
- JANUVIA (Drug) $76.87
- Trintellix (Drug) $54.26
- BYSTOLIC (Drug) $50.15
- BYDUREON (Drug) $47.61
- SYMBICORT (Drug) $44.41
- FLUZONE HIGH-DOSE (Drug) $42.10
- UBRELVY (Drug) $41.83
- EMGALITY (Drug) $41.29
- CHANTIX (Drug) $30.58
- Tresiba (Drug) $29.82
- TOUJEO (Drug) $26.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.